Filed: Jun. 03, 2008
Latest Update: Feb. 22, 2020
Summary: REVISED MAY 30, 2008 IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT United States Court of Appeals Fifth Circuit FILED May 8, 2008 No. 06-30745 Charles R. Fulbruge III Clerk KADLEC MEDICAL CENTER; WESTERN PROFESSIONAL INSURANCE COMPANY Plaintiffs - Appellees - Cross-Appellants v. LAKEVIEW ANESTHESIA ASSOCIATES, A Professional Medical Corporation; LAKEVIEW MEDICAL CENTER LLC, doing business as Lakeview Regional Medical Center; DR MARK DENNIS; DR WILLIAM J PREAU, III Defendants - Appe
Summary: REVISED MAY 30, 2008 IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT United States Court of Appeals Fifth Circuit FILED May 8, 2008 No. 06-30745 Charles R. Fulbruge III Clerk KADLEC MEDICAL CENTER; WESTERN PROFESSIONAL INSURANCE COMPANY Plaintiffs - Appellees - Cross-Appellants v. LAKEVIEW ANESTHESIA ASSOCIATES, A Professional Medical Corporation; LAKEVIEW MEDICAL CENTER LLC, doing business as Lakeview Regional Medical Center; DR MARK DENNIS; DR WILLIAM J PREAU, III Defendants - Appel..
More
REVISED MAY 30, 2008
IN THE UNITED STATES COURT OF APPEALS
FOR THE FIFTH CIRCUIT United States Court of Appeals
Fifth Circuit
FILED
May 8, 2008
No. 06-30745 Charles R. Fulbruge III
Clerk
KADLEC MEDICAL CENTER; WESTERN PROFESSIONAL INSURANCE
COMPANY
Plaintiffs - Appellees - Cross-Appellants
v.
LAKEVIEW ANESTHESIA ASSOCIATES, A Professional Medical
Corporation; LAKEVIEW MEDICAL CENTER LLC, doing business as
Lakeview Regional Medical Center; DR MARK DENNIS; DR WILLIAM J
PREAU, III
Defendants - Appellants - Cross-Appellees
DR DAVID BALDONE; DR ALLAN PARR
Defendants - Cross-Appellees
Appeal from the United States District Court
for the Eastern District of Louisiana
Before REAVLEY, BENAVIDES, and ELROD, Circuit Judges.
REAVLEY, Circuit Judge:
Kadlec Medical Center and its insurer, Western Professional Insurance
Company, filed this diversity action in Louisiana district court against Louisiana
Anesthesia Associates (LAA), its shareholders, and Lakeview Regional Medical
Center (Lakeview Medical). The LAA shareholders worked with Dr. Robert
Berry—an anesthesiologist and former LAA shareholder—at Lakeview Medical,
where the defendants discovered his on-duty use of narcotics. In referral letters
written by the defendants and relied on by Kadlec, his future employer, the
defendants did not disclose Dr. Berry’s drug use.
While under the influence of Demerol at Kadlec, Dr. Berry’s negligent
performance led to the near-death of a patient, resulting in a lawsuit against
Kadlec. Plaintiffs claim here that the defendants’ misleading referral letters
were a legal cause of plaintiffs’ financial injury, i.e., having to pay over $8
million to defend and settle the lawsuit. The jury found in favor of the plaintiffs
and judgment followed. We reverse the judgment against Lakeview Medical,
vacate the remainder of the judgment, and remand.
I. Factual Background
Dr. Berry was a licensed anesthesiologist in Louisiana and practiced with
Drs. William Preau, Mark Dennis, David Baldone, and Allan Parr at LAA. From
November 2000 until his termination on March 13, 2001, Dr. Berry was a
shareholder of LAA, the exclusive provider of anesthesia services to Lakeview
Medical (a Louisiana hospital).
In November 2000, a small management team at Lakeview Medical
investigated Dr. Berry after nurses expressed concern about his undocumented
and suspicious withdrawals of Demerol. The investigative team found excessive
Demerol withdrawals by Dr. Berry and a lack of documentation for the
withdrawals.
Lakeview Medical CEO Max Lauderdale discussed the team’s findings
with Dr. Berry and Dr. Dennis. Dr. Dennis then discussed Dr. Berry’s situation
with his partners. They all agreed that Dr. Berry’s use of Demerol had to be
controlled and monitored. But Dr. Berry did not follow the agreement or account
for his continued Demerol withdrawals. Three months later, Dr. Berry failed to
2
answer a page while on-duty at Lakeview Medical. He was discovered in the
call-room, asleep, groggy, and unfit to work. Personnel immediately called Dr.
Dennis, who found Dr. Berry not communicating well and unable to work. Dr.
Dennis had Dr. Berry taken away after Dr. Berry said that he had taken
prescription medications.
Lauderdale, Lakeview Medical’s CEO, decided that it was in the best
interest of patient safety that Dr. Berry not practice at the hospital. Dr. Dennis
and his three partners at LAA fired Dr. Berry and signed his termination letter
on March 27, 2001, which explained that he was fired “for cause”:
[You have been fired for cause because] you have reported to work
in an impaired physical, mental, and emotional state. Your impaired
condition has prevented you from properly performing your duties
and puts our patients at significant risk. . . . [P]lease consider your
termination effective March 13, 2001.
At Lakeview Medical, Lauderdale ordered the Chief Nursing Officer to notify the
administration if Dr. Berry returned.
Despite recognizing Dr. Berry’s drug problem and the danger he posed to
patients, neither Dr. Dennis nor Lauderdale reported Dr. Berry’s impairment to
the hospital’s Medical Executive Committee, eventually noting only that Dr.
Berry was “no longer employed by LAA.” Neither one reported Dr. Berry’s
impairment to Lakeview Medical’s Board of Trustees, and no one on behalf of
Lakeview Medical reported Dr. Berry’s impairment or discipline to the Louisiana
Board of Medical Examiners or to the National Practitioner’s Data Bank. In
fact, at some point Lauderdale took the unusual step of locking away in his office
all files, audits, plans, and notes concerning Dr. Berry and the investigation.
After leaving LAA and Lakeview Medical, Dr. Berry briefly obtained work
as a locum tenens (traveling physician) at a hospital in Shreveport, Louisiana.
In October 2001, he applied through Staff Care, a leading locum tenens staffing
3
firm, for locum tenens privileges at Kadlec Medical Center in Washington State.
After receiving his application, Kadlec began its credentialing process. Kadlec
examined a variety of materials, including referral letters from LAA and
Lakeview Medical.
LAA’s Dr. Preau and Dr. Dennis, two months after firing Dr. Berry for his
on-the-job drug use, submitted referral letters for Dr. Berry to Staff Care, with
the intention that they be provided to future employers. The letter from Dr.
Dennis stated that he had worked with Dr. Berry for four years, that he was an
excellent clinician, and that he would be an asset to any anesthesia service. Dr.
Preau’s letter said that he worked with Berry at Lakeview Medical and that he
recommended him highly as an anesthesiologist. Dr. Preau’s and Dr. Dennis’s
letters were submitted on June 3, 2001, only sixty-eight days after they fired him
for using narcotics while on-duty and stating in his termination letter that Dr.
Berry’s behavior put “patients at significant risk.”
On October 17, 2001, Kadlec sent Lakeview Medical a request for
credentialing information about Berry. The request included a detailed
confidential questionnaire, a delineation of privileges, and a signed consent for
release of information. The interrogatories on the questionnaire asked whether
“[Dr. Berry] has been subject to any disciplinary action,” if “[Dr. Berry has] the
ability (health status) to perform the privileges requested,” whether “[Dr. Berry
has] shown any signs of behavior/personality problems or impairments,” and
whether Dr. Berry has satisfactory “judgement.”
Nine days later, Lakeview Medical responded to the requests for
credentialing information about fourteen different physicians. In thirteen cases,
it responded fully and completely to the request, filling out forms with all the
information asked for by the requesting health care provider. The fourteenth
request, from Kadlec concerning Berry, was handled differently. Instead of
4
completing the multi-part forms, Lakeview Medical staff drafted a short letter.
In its entirety, it read:
This letter is written in response to your inquiry regarding
[Dr. Berry]. Due to the large volume of inquiries received in this
office, the following information is provided.
Our records indicate that Dr. Robert L. Berry was on the
Active Medical Staff of Lakeview Regional Medical Center in the
field of Anesthesiology from March 04, 1997 through September 04,
2001.
If I can be of further assistance, you may contact me at (504)
867-4076.
The letter did not disclose LAA’s termination of Dr. Berry; his on-duty
drug use; the investigation into Dr. Berry’s undocumented and suspicious
withdrawals of Demerol that “violated the standard of care”; or any other
negative information. The employee who drafted the letter said at trial that she
just followed a form letter, which is one of many that Lakeview Medical used.
Kadlec then credentialed Dr. Berry, and he began working there. After
working at Kadlec without incident for a number of months, he moved
temporarily to Montana where he worked at Benefis Hospital. During his stay
in Montana, he was in a car accident and suffered a back injury. Kadlec’s head
of anesthesiology and the credentialing department all knew of Dr. Berry’s
accident and back injury, but they did not investigate whether it would impair
his work.
After Dr. Berry returned to Kadlec, some nurses thought that he appeared
sick and exhibited mood swings. One nurse thought that Dr. Berry’s entire
demeanor had changed and that he should be watched closely. In mid-
September 2002, Dr. Berry gave a patient too much morphine during surgery,
and she had to be revived using Narcan. The neurosurgeon was irate about the
incident.
5
On November 12, 2002, Dr. Berry was assigned to the operating room
beginning at 6:30 a.m. He worked with three different surgeons and multiple
nurses well into the afternoon. According to one nurse, Dr. Berry was “screwing
up all day” and several of his patients suffered adverse affects from not being
properly anesthetized. He had a hacking cough and multiple nurses thought he
looked sick. During one procedure, he apparently almost passed out.
Kimberley Jones was Dr. Berry’s fifth patient that morning. She was in
for what should have been a routine, fifteen minute tubal ligation. When they
moved her into the recovery room, one nurse noticed that her fingernails were
blue, and she was not breathing. Dr. Berry failed to resuscitate her, and she is
now in a permanent vegetative state.
Dr. Berry’s nurse went directly to her supervisor the next morning and
expressed concern that Dr. Berry had a narcotics problem. Dr. Berry later
admitted to Kadlec staff that he had been diverting and using Demerol since his
June car accident in Montana and that he had become addicted to Demerol. Dr.
Berry wrote a confession, and he immediately admitted himself into a drug
rehabilitation program.
Jones’s family sued Dr. Berry and Kadlec in Washington. Dr. Berry’s
insurer settled the claim against him. After the Washington court ruled that
Kadlec would be responsible for Dr. Berry’s conduct under respondeat superior,
Western, Kadlec’s insurer, settled the claim against Kadlec.
II. Procedural History
Kadlec and Western filed this suit in Louisiana district court against LAA,
Dr. Dennis, Dr. Preau, Dr. Baldone, Dr. Parr, and Lakeview Medical, asserting
Louisiana state law claims for intentional misrepresentation, negligent
misrepresentation, strict responsibility misrepresentation, and general
negligence. Plaintiffs alleged that defendants’ tortious activity led to Kadlec’s
6
hiring of Dr. Berry and the resulting millions of dollars it had to expend settling
the Jones lawsuit. Plaintiffs’ claim against LAA for negligence, based on a
negligent monitoring and investigation theory, was dismissed before trial.
Plaintiffs’ surviving claims for intentional and negligent misrepresentation
arise out of the alleged misrepresentations in, and omissions from, the
defendants’ referral letters for Dr. Berry. These claims were tried to a jury,
which returned a verdict in favor of the plaintiffs on both claims. The jury
awarded plaintiffs $8.24 million, which is approximately equivalent to the
amount Western spent settling the Jones lawsuit ($7.5 million) plus the amount
it spent on attorneys fees, costs, and expenses (approximately $744,000)
associated with the Jones lawsuit. The jury also found Kadlec and Dr. Berry
negligent. The jury apportioned fault as follows: Dr. Dennis 20%; Dr. Preau 5%;
Lakeview Medical 25%; Kadlec 17%; and Dr. Berry 33%. The judgments against
Dr. Dennis and Dr. Preau were in solido with LAA. Because defendants were
found liable for intentional misrepresentation, plaintiffs’ recovery was not
reduced by the percentage of fault ascribed to Kadlec.1 But the amount was
reduced to $5.52 million to account for Dr. Berry’s 33% of the fault.2 The district
court entered judgment against Lakeview Medical and LAA.
III. Discussion
A. The Intentional and Negligent Misrepresentation Claims
The plaintiffs allege that the defendants committed two torts: intentional
misrepresentation and negligent misrepresentation.3 The elements of a claim
1
LA. CIV. CODE art. 2323(C).
2
No complaint has been made, in the district court or to this court, about allocating
fault to Dr. Berry in this case.
3
Plaintiffs contend that the defendants’ torts caused them an economic loss, which is
a cognizable claim in Louisiana, “a jurisdiction which allows recovery in tort for purely
7
for intentional misrepresentation in Louisiana are: (1) a misrepresentation of a
material fact; (2) made with intent to deceive; and (3) causing justifiable reliance
with resultant injury.4 To establish a claim for intentional misrepresentation
when it is by silence or inaction, plaintiffs also must show that the defendant
owed a duty to the plaintiff to disclose the information.5 To make out a negligent
misrepresentation claim in Louisiana: (1) there must be a legal duty on the part
of the defendant to supply correct information; (2) there must be a breach of that
duty, which can occur by omission as well as by affirmative misrepresentation;
and (3) the breach must have caused damages to the plaintiff based on the
plaintiff’s reasonable reliance on the misrepresentation.6
The defendants argue that any representations in, or omissions from, the
referral letters cannot establish liability. We begin our analysis below by
holding that after choosing to write referral letters, the defendants assumed a
duty not to make affirmative misrepresentations in the letters. We next analyze
whether the letters were misleading, and we conclude that the LAA defendants’
letters were misleading, but the letter from Lakeview Medical was not. We also
examine whether the defendants had an affirmative duty to disclose negative
information about Dr. Berry in their referral letters, and we conclude that there
was not an affirmative duty to disclose. Based on these holdings, Lakeview
Medical did not breach any duty owed to Kadlec, and therefore the judgment
economic loss.” Barrie v. V.P. Exterminators, Inc.,
625 So. 2d 1007, 1014 (La. 1993).
4
Guidry v. United States Tobacco Co.,
188 F.3d 619, 627 (5th Cir. 1999).
5
See Greene v. Gulf Coast Bank,
593 So. 2d 630, 632 (La. 1992).
6
Brown v. Forest Oil Corp.,
29 F.3d 966, 969 (5th Cir. 1994); In re Ward,
894 F.2d 771,
776 (5th Cir. 1990); Pastor v. Lafayette Bldg. Ass’n,
567 So. 2d 793, 796 (La. Ct. App. 1990);
Cypress Oilfield Contractors, Inc. v. McGoldrick Oil Co.,
525 So. 2d 1157, 1162 (La. Ct. App.
1988).
8
against it is reversed. Finally, we examine other challenges to the LAA
defendants’ liability, and we conclude that they are without merit.
1. The Affirmative Misrepresentations
The defendants owed a duty to Kadlec to avoid affirmative
misrepresentations in the referral letters. In Louisiana, “[a]lthough a party
may keep absolute silence and violate no rule of law or equity, . . . if he
volunteers to speak and to convey information which may influence the conduct
of the other party, he is bound to [disclose] the whole truth.”7 In negligent
misrepresentation cases, Louisiana courts have held that even when there is no
initial duty to disclose information, “once [a party] volunteer[s] information, it
assume[s] a duty to insure that the information volunteered [is] correct.”8
Consistent with these cases, the defendants had a legal duty not to make
affirmative misrepresentations in their referral letters. A party does not incur
liability every time it casually makes an incorrect statement. But if an employer
makes a misleading statement in a referral letter about the performance of its
former employee, the former employer may be liable for its statements if the
facts and circumstances warrant. Here, defendants were recommending an
anesthesiologist, who held the lives of patients in his hands every day. Policy
considerations dictate that the defendants had a duty to avoid
misrepresentations in their referral letters if they misled plaintiffs into thinking
that Dr. Berry was an “excellent” anesthesiologist, when they had information
7
Am. Guar. Co. v. Sunset Realty & Planting Co.,
23 So. 2d 409, 455–56 (La. 1944).
8
See, e.g.,
Pastor, 567 So. 2d at 796; accord Leon v. Moore,
896 So. 2d 1073, 1076 (La.
Ct. App. 2004) (holding that “[t]here is no general duty to speak, but if one does speak, he may
be liable for any intentional misrepresentation (fraud) or any negligent misrepresentation”);
Cypress Oilfield Contractors,
Inc., 525 So. 2d at 1162 (holding that although a bank did not owe
a duty of disclosure to the plaintiff, a non-customer, the bank “assumed a duty to insure that
the information volunteered was correct”).
9
that he was a drug addict. Indeed, if defendants’ statements created a
misapprehension about Dr. Berry’s suitability to work as an anesthesiologist,
then by “volunteer[ing] to speak and to convey information which . . .
influence[d] the conduct of [Kadlec], [they were] bound to [disclose] the whole
truth.”9 In other words, if they created a misapprehension about Dr. Berry due
to their own statements, they incurred a duty to disclose information about his
drug use and for-cause firing to complete the whole picture.
We now review whether there is evidence that the defendants’ letters were
misleading. We start with the LAA defendants. The letter from Dr. Preau
stated that Dr. Berry was an “excellent anesthesiologist” and that he
“recommend[ed] him highly.” Dr. Dennis’s letter said that Dr. Berry was “an
excellent physician” who “he is sure will be an asset to [his future employer’s]
anesthesia service.” These letters are false on their face and materially
misleading. Notably, these letters came only sixty-eight days after Drs. Dennis
and Preau, on behalf of LAA, signed a letter terminating Dr. Berry for using
narcotics while on-duty and stating that Dr. Berry’s behavior put “patients at
significant risk.” Furthermore, because of the misleading statements in the
letters, Dr. Dennis and Dr. Preau incurred a duty to cure these misleading
statements by disclosing to Kadlec that Dr. Berry had been fired for on-the-job
drug use.
The question as to whether Lakeview Medical’s letter was misleading is
more difficult. The letter does not comment on Dr. Berry’s proficiency as an
anesthesiologist, and it does not recommend him to Kadlec. Kadlec says that the
letter is misleading because Lakeview Medical stated that it could not reply to
Kadlec’s detailed inquiry in full “[d]ue to the large volume of inquiries received.”
9
Sunset
Realty, 23 So. 2d at 455–56.
10
But whatever the real reason that Lakeview Medical did not respond in full to
Kadlec’s inquiry, Kadlec did not present evidence that this could have
affirmatively misled it into thinking that Dr. Berry had an uncheckered history
at Lakeview Medical.
Kadlec also says that the letter was misleading because it erroneously
reported that Dr. Berry was on Lakeview Medical’s active medical staff until
September 4, 2001. Kadlec presented testimony that had it known that Dr.
Berry never returned to Lakeview Medical after March 13, 2001, it would have
been suspicious about the apparently large gap in his employment. While it is
true that Dr. Berry did not return to Lakeview Medical after March 13, this did
not terminate his privileges at the hospital, or mean that he was not on “active
medical staff.” In fact, it appears that Dr. Berry submitted a formal resignation
letter on October 1, 2001, weeks after September 4. Therefore, while the
September 4 date does not accurately reflect when Dr. Berry was no longer on
Lakeview Medical’s active medical staff, it did not mislead Kadlec into thinking
that he had less of a gap in employment than he actually had.
In sum, we hold that the letters from the LAA defendants were
affirmatively misleading, but the letter from Lakeview Medical was not.
Therefore, Lakeview Medical cannot be held liable based on its alleged
affirmative misrepresentations. It can only be liable if it had an affirmative duty
to disclose information about Dr. Berry. We now examine the theory that, even
assuming that there were no misleading statements in the referral letters, the
defendants had an affirmative duty to disclose. We discuss this theory with
regard to both defendants for reasons that will be clear by the end of the opinion.
2. The Duty to Disclose
In Louisiana, a duty to disclose does not exist absent special
circumstances, such as a fiduciary or confidential relationship between the
11
parties, which, under the circumstances, justifies the imposition of the duty.10
Louisiana cases suggest that before a duty to disclose is imposed the defendant
must have had a pecuniary interest in the transaction.11 In Louisiana, the
existence of a duty is a question of law,12 and we review the duty issue here de
novo.13
Plaintiffs assert that Lakeview Medical and the LAA doctors had a
pecuniary interest in the referral letters supplied to Kadlec. The plaintiffs rely
10
See Wilson v. Mobil Oil Corp.,
940 F. Supp. 944, 955 (E.D. La. 1996) (citing Greene
v. Gulf Coast Bank,
593 So. 2d 630, 632 (La. 1992) and First Downtown Dev. v. Cimochowski,
613 So. 2d 671, 677 (La. Ct. App. 1993)); Bunge Corp. v. GATX Corp.,
557 So. 2d 1376,
1383–84 (La. 1990).
11
See
Barrie, 625 So. 2d at 1017 (“due to V.P.’s pecuniary interest in supplying the
information, the duty arose to exercise reasonable care”). In McLachlan v. New York Life Ins.
Co.,
488 F.3d 624 (5th Cir. 2007), relied on by the defendants, this court said in the middle of
one paragraph that under Louisiana law a duty to disclose exists only where there is privity
of contract or a fiduciary relationship between the parties.
Id. at 628. But later in the same
paragraph the court acknowledged that the Louisiana Supreme Court has imposed a duty to
disclose where there was no privity or fiduciary relationship.
Id. Our review of Louisiana
cases confirms that there does not need to be privity of contract or a fiduciary relationship for
there to be a duty to disclose. See, e.g., Barrie,
625 So. 2d. at 1014 (holding that “Louisiana
is a jurisdiction which allows recovery in tort for . . . negligent misrepresentation where privity
of contract is absent”). The Louisiana Supreme Court has said elsewhere that “[i]t has long
been held that the duty to disclose exists” where the parties have a confidential relationship
with each other, and the court explained that “[t]he confidential relationship is not restricted
to any specific association of the parties,” but exists between “generally all persons who are
associated by any relation of trust and confidence.”
Bunge, 557 So. 2d at 1383–84 & n.4
(internal quotation marks omitted). Therefore, we must look carefully at the facts of this case
to determine whether there was a duty to disclose. See Barrie,
625 So. 2d at 1016
(“Louisiana’s case by case development of the tort of negligent misrepresentation has not been
restricted to a set theory. . . . Adopting one of the common law standards as the sole method
for determining liability for this tort is not necessary. The case by case application of the
duty/risk analysis, presently employed by our courts, adequately protects the misinformer and
the misinformed because the initial inquiry is whether, as a matter of law, a duty is owed to
this particular plaintiff to protect him from this particular harm.”).
12
Bunge, 557 So. 2d at 1384.
13
Bursztajn v. United States,
367 F.3d 485, 489 (5th Cir. 2004).
12
on the pecuniary interest definition in the Second Restatement of Torts. Section
552, comment d of the Restatement, provides (with emphasis added):
The defendant’s pecuniary interest in supplying the
information will normally lie in a consideration paid to him for it or
paid in a transaction in the course of and as a part of which it is
supplied. It may, however, be of a more indirect character. . . .
The fact that the information is given in the course of
the defendant’s business, profession or employment is a
sufficient indication that he has a pecuniary interest in it,
even though he receives no consideration for it at the time.
It is not, however, conclusive. . . .
The “course of business” definition of pecuniary interest has been endorsed
by Louisiana appellate courts. In Anderson v. Heck, the court defined the
“pecuniary interest” of the defendant by directly quoting and applying the
portion of the Restatement comment highlighted above.14 The court in Dousson
v. South Central Bell held that the fact that information is given in the course
of a party’s business or profession is a sufficient indication of pecuniary interest
even though the party receives no consideration for it at the time.15
The defendants argue that, even assuming the Restatement governs, they
did not have a pecuniary interest in providing reference information. They
contend that any information provided to future employers about Dr. Berry was
gratuitous, and they point out that the Restatement’s comments say that a party
will not be considered to have a pecuniary interest in a transaction where the
information is given “purely gratuitously.”16
The defendants have the better argument on the lack of pecuniary interest
14
554 So. 2d 695, 705 (La. Ct. App. 1989). The court also held that the “pecuniary
interest” necessary to establish a duty “need not be direct or immediate.”
Id.
15
429 So. 2d 466, 468 (La. Ct. App. 1983).
16
RESTATEMENT (SECOND) OF TORTS § 552 cmt. c.
13
and, in addition, the requisite “special relationship” between the defendants and
Kadlec, necessary to impose a duty to disclose, is lacking.17
Plaintiffs argue that policy considerations weigh in favor of recognizing a
duty to disclose. They contend that imposing a duty on health care employers
to disclose that a physician’s drug dependence could pose a serious threat to
patient safety promotes important policy goals recognized by Louisiana courts.
Plaintiffs point to the decision in Dornak v. Lafayette General Hospital, where
the Louisiana Supreme Court imposed on a hospital the duty to disclose to its
employee the results of a pre-employment physical which showed tuberculosis,
“especially considering the fact that . . . [her] duties plac[ed] her in contact with
co-employees and hospital patients.”18 The Louisiana legislature recently
adopted legislation that requires health care entities to “report [to the
appropriate professional licensing board] each instance in which the health care
entity . . . [t]akes an adverse action against a health care professional due to
impairment or possible impairment.”19 This shows that the legislature has
recognized the importance of reporting possible impairments that could affect
patient safety.
Despite these compelling policy arguments, we do not predict that courts
in Louisiana—absent misleading statements such as those made by the LAA
defendants—would impose an affirmative duty to disclose. The defendants did
not have a fiduciary or contractual duty to disclose what it knew to Kadlec. And
17
See Barrie,
625 So. 2d at 1016 (determining whether there is a duty to disclose must
be made on a case-by-case basis); see also
Wilson, 940 F. Supp. at 955;
Greene, 593 So. 2d at
632; First
Downtown, 613 So. 2d at 677 (all emphasizing the need to find a special relationship
between the parties before imposition of a duty to disclose).
18
399 So. 2d 168, 170 (La. 1981).
19
LA. REV. STAT. § 37:1745.14.
14
although the defendants might have had an ethical obligation to disclose their
knowledge of Dr. Berry’s drug problems, they were also rightly concerned about
a possible defamation claim if they communicated negative information about
Dr. Berry.20 As a general policy matter, even if an employer believes that its
disclosure is protected because of the truth of the matter communicated, it would
be burdensome to impose a duty on employers, upon receipt of a employment
referral request, to investigate whether the negative information it has about an
employee fits within the courts’ description of which negative information must
be disclosed to the future employer. Finally, concerns about protecting employee
privacy weigh in favor of not mandating a potentially broad duty to disclose.
The Louisiana court in Louviere recognized that no court in Louisiana has
imposed on an employer a duty to disclose information about a former employee
to a future employer.21 Furthermore, we have not found a single case outside of
Louisiana where a court imposed an affirmative duty on an employer to disclose
negative information about a former employee.22 Some courts have held that
employers have a legal duty to disclose negative information about former
employees who later cause foreseeable physical harm in their new jobs, at least
20
See Louviere v. Louviere,
839 So. 2d 57, 64 (La. Ct. App. 2002) (“[I]f a former employer
gives negative information about an employee to a prospective employer, this can result in
exposure to a defamation claim.”).
21
Id. at 62. The court also said that it did not believe that under Louisiana law there
is a duty of a former employer to disclose information about a former employee.
Id. We do not
simply rely on this statement alone because we must follow the Louisiana Supreme Court and
engage in a careful case specific analysis, guided by the policy considerations discussed by the
Louisiana Supreme Court, to determine whether there was a duty to disclose under the facts
here. We also note that the Louviere court itself engaged in an intensive fact analysis to see
if there was liability.
Id. at 62–67.
22
Louisiana courts look to other jurisdictions for help when deciding legal duty
questions. Posecai v. Wal-Mart Stores, Inc.,
752 So. 2d 762, 766 (La. 1999).
15
when there are misleading statements made by the former employer.23 But each
of these cases based its conclusion on the fact that the former employer had
made affirmative misrepresentations in its referral, and none imposed a duty
based on the employer’s mere nondisclosure.24 These cases reinforce our
conclusion that the defendants had a duty to avoid misleading statements in
their referral letters, but they do not support plaintiffs’ duty to disclose theory.
In fact, one court explicitly held that a hospital did not have an affirmative duty
to disclose a nurse’s past sexual misconduct toward patients when asked for an
evaluation by a prospective employer, but that “[the defendant did] not challenge
the proposition that, in undertaking to provide . . . a reference, and in
volunteering information about [the employee’s] qualities as a nurse, it incurred
a duty to use reasonable care to avoid disclosing factually misleading
information.”25
3. Legal Cause
LAA contends that even if it breached a legal duty to Kadlec, the plaintiffs’
claims fail for lack of legal causation. LAA argues that legal cause is not met
here because Kadlec’s and Dr. Berry’s intervening negligence precludes
concluding that it is a legal cause of plaintiffs’ injuries. Because legal cause is
23
See, e.g., Gutzan v. Altair Airlines, Inc.,
766 F.2d 135, 137 (3d Cir. 1985); Randi W.
v. Muroc Joint Unified Sch. Dist.,
929 P.2d 582 (Cal. 1997); Davis v. Bd. of County Commr’s
of Doña Ana County,
987 P.2d 1172 (N.M. Ct. App. 1999).
24
Gutzan, 766 F.2d at 139, 140–41; Randi
W., 929 P.2d at 591–93 (“[H]aving
volunteered . . . information, defendants were obliged to complete the picture by disclosing
material facts regarding charges and complaints of [the employee’s] sexual improprieties.”);
Davis, 987 P.2d at 1177–80.
25
Grozdanich v. Leisure Hills Health Ctr., Inc.,
25 F. Supp. 2d 953, 989–90 (D. Minn.
1998). The court continued: “It is well-settled that, even if one has no duty to disclose a
particular fact, if one chooses to speak he must say enough to prevent the words from
misleading the other party.”
Id. at 990 (internal quotation marks omitted).
16
a legal question under Louisiana law,26 we review the district court’s conclusion
as to legal cause de novo.27
The leading case on legal cause in Louisiana is Roberts v. Benoit.28 There,
the Louisiana Supreme Court held that “[t]he critical test in Louisiana . . . is
phrased in terms of ‘the ease of association’ which melds policy and foreseeability
into one inquiry: Is the harm which befell the plaintiff easily associated with the
type of conduct engaged in by the defendant?”29 Under Louisiana law, and with
the jury’s factual findings in mind,30 the LAA defendants’ actions and omissions
were a legal cause of Kadlec’s liability. Following the Louisiana Supreme Court,
we ask ourselves whether the harm to plaintiffs is easily associated with the
type of conduct engaged in by the defendant. Here, Dr. Dennis and Dr. Preau
gave Dr. Berry favorable recommendations, when they knew that Dr. Berry had
used narcotic drugs while on duty at a hospital. LAA even fired Dr. Berry for
cause for “report[ing] to work in an impaired physical, mental, and emotional
state, which prevented [him] from properly performing [his] duties and put[]
[his] patients at significant risk.” The harm to Jones and the harm to plaintiffs
that resulted from the LAA defendants’ breaches are “easily associated” with
Kadlec’s liability. In fact, harm stemming from Dr. Berry’s use of narcotic drugs
26
Todd v. State Through Dep’t of Soc. Servs.,
699 So. 2d 35, 39 (La. 1997).
27
In re Liljeberg Enterprises, Inc.,
304 F.3d 410, 423 (5th Cir. 2002).
28
605 So. 2d 1032 (La. 1992).
29
Id. at 1054.
30
This court reviews legal conclusions independently, but reviews findings of fact, as
well as mixed questions of law and fact, under the less stringent clear error standard. In re
Liljeberg
Enterprises, 304 F.3d at 423–24. We review the legal causation question
independently. But we must consider the facts relevant to our legal cause analysis consistent
with the jury’s verdict.
17
while on-duty is the type of harm we would expect.
The LAA defendants’ argument that the intervening negligence of Dr.
Berry and Kadlec absolves them of liability is not accepted. Roberts held that
“[i]t is well settled in Louisiana law that an intervening act does not
automatically absolve a prior negligent party from liability.”31 Whether an
intervening act absolves a prior negligent actor from liability depends on the
foreseeability of the act from the perspective of the original tortfeasor and
whether the intervening act is “easily associated” with the risk of harm brought
about by the breach of the original duty.32 Dr. Berry’s hiring and his subsequent
negligent use of narcotics while on-duty was foreseeable and “easily associated”
with the LAA defendants’ actions. He had used narcotics while on-duty in the
past, and the LAA defendants could foresee that he would do so again if they
misled a future employer about his drug problem.
The LAA defendants focus on Kadlec’s negligence and claim that it was a
superseding cause of plaintiffs’ injuries. They argue that Kadlec had multiple
warning signs that Dr. Berry was using drugs, and had it responded with an
investigation, plaintiffs’ injuries would have been avoided. The LAA defendants
focus on Dr. Berry’s erratic behavior after his return from Montana, his over-
anesthetization of a patient in September 2002, and the signs that he was ill on
the day of Jones’s surgery. The jury found that Kadlec’s own negligence was a
cause of plaintiffs’ financial injury. But this does not relieve the defendants of
liability. The jury also reasonably concluded that the LAA defendants
negligently and intentionally misled Kadlec about Dr. Berry’s drug addiction.
31
605 So. 2d at 1055.
32
Id. at 1055–56 (citing Jones v. Robbins,
289 So. 2d 104 (La. 1974) and LeJeune v.
Allstate Ins. Co.,
365 So. 2d 471 (La. 1978)).
18
By intentionally covering up Dr. Berry’s drug addiction in communications with
a future employer, they should have foreseen that the future employer might
miss the warning signs of Dr. Berry’s addiction. This was within the scope of the
risk they took.
Indeed, both plaintiffs’ and defendants’ witnesses agreed at trial that
narcotics addiction is a disease, that addicts try to hide their disease from their
co-workers, and that particularly in the case of narcotics-addicted
anesthesiologists, for whom livelihood and drug supply are in the same place,
colleagues may be the last to know about their addiction and impairment. This
is not a case where a future tortious act is so unforeseeable that it should relieve
the earlier tortfeasor of liability. In fact, this case illustrates why the
comparative fault system was developed—so, as here, multiple actors can share
fault for an injury based on their respective degrees of responsibility.33
4. Tort Indemnity and Contribution
Defendants claim that the district court should have dismissed this action
because Louisiana does not allow contribution or indemnity claims, and this suit,
properly characterized, is one for contribution or indemnity. The defendants
have not provided this court with any relevant legal authority for the proposition
that this is a contribution or indemnity suit in disguise. Moreover, defendants’
argument fails because plaintiffs sued based on the theory that Lakeview
Medical and the LAA defendants breached a duty to Kadlec by making
intentional and negligent misrepresentations about Dr. Berry in the referral
letters supplied to Kadlec. As a result of these misrepresentations, plaintiffs
33
See Mendoza v. Mashburn,
747 So. 2d 1159, 1168, 1173 (La. Ct. App. 1999) (holding
that “[a]n initial tortfeaser will not be relieved of the consequences of his negligence unless the
intervening cause superceded the original negligence and alone produced the injury,” and
reinstating a jury’s findings of comparative fault).
19
suffered a foreseeable financial injury in excess of $8 million. This is not a
lawsuit asking for contribution or indemnity. It is a lawsuit that alleges
breaches of duties owed to Kadlec. Therefore, defendants’ argument is rejected.
We are not convinced by defendants’ other challenges to plaintiffs’
intentional and negligent misrepresentation claims. In particular, LAA
complains that there was insufficient evidence that Kadlec reasonably relied on
the letters from Dr. Preau and Dr. Dennis. We disagree.
B. Evidence of Western’s Reinsurance
The defendants argue that the district court erred when it granted
plaintiffs in limine request under the collateral source rule to exclude evidence
of Western’s reinsurance. After Western expended $744,000 on litigation costs
and settled the Jones lawsuit against Kadlec for $7.5 million, it received
payment for a portion of its expenditures from its reinsurers. The defendants
sought unsuccessfully to introduce this reinsurance information to the jury. We
review the district court’s evidentiary ruling for an abuse of discretion.34
As adopted by the Louisiana Supreme Court, the collateral source rule is
a rule of evidence and damages. The rule provides that payments made to or
benefits conferred upon an injured party from sources other than the tortfeasor,
notwithstanding that such payments or benefits cover all or a part of the harm
for which the tortfeasor is liable, are not credited against the tortfeasor’s
liability.35 The policy driving the rule is the belief that a tortfeasor should not
benefit because a plaintiff had the foresight to obtain insurance.36 Here,
34
United States v. Sumlin,
489 F.3d 683, 688 (5th Cir. 2007).
35
See Bozeman v. State,
879 So. 2d 692, 697 (La. 2004) (noting that the common law
collateral source rule has its source in the Restatement of Torts and that it has been embraced
by Louisiana courts).
36
Id. at 698.
20
although the plaintiffs incurred damages in excess of $8 million as a result of
defendants’ torts (and Dr. Berry’s and Kadlec’s own tortious behavior, which the
jury considered), defendants wanted to introduce evidence of Western’s
reinsurance to show plaintiffs’ “real injury.” But this is nothing more than a
classic argument against the collateral source rule, and it would effectively
penalize Western for having the foresight to obtain reinsurance. While there are
exceptions to the collateral source rule that allow a party to introduce evidence
of reinsurance,37 they are inapplicable here.
C. Plaintiffs’ Attorney’s Fees in the Jones Litigation
The district court denied defendants’ motion in limine to keep from the
jury evidence of the money plaintiffs were forced to spend to defend the Jones’s
lawsuit. The jury verdict included these costs and attorney’s fees. Defendants
argue that plaintiffs should not have been allowed to recover attorney’s fees
spent defending the underling lawsuit. We review this evidentiary ruling for an
abuse of discretion.38
We hold that the district court properly denied defendants’ motion. While
there is no Louisiana case directly on point, this conclusion is consistent with the
rule found in Section 914(2) of the Second Restatement of Torts:
One who through the tort of another has been required to act in the
protection of his interests by bringing or defending an action against
a third person is entitled to recover reasonable compensation for
37
For example, in Am. Fidelity & Cas. Co. v. Greyhound Corp.,
258 F.2d 709 (5th Cir.
1958), we held that evidence of reinsurance was admissible to show an insurer’s good faith in
settling or not settling underlying litigation against its insured for a certain amount.
Defendants’ reliance on American Fidelity is misplaced because that case was about whether
the insurer showed bad faith in choosing whether or not to settle the underlying lawsuit
because of its reinsurance limits.
Id. at 712. By contrast, the defendants want to introduce
evidence of Western’s reinsurance to show plaintiffs’ “real injury,” i.e., the amount that
defendants’ tortious activities truly harmed plaintiffs.
38
Sumlin, 489 F.3d at 688.
21
loss of time, attorney fees and other expenditures thereby suffered
or incurred in the earlier action.
Plaintiffs, due to the torts of the defendants, were required to expend costs and
attorney’s fees defending the Jones lawsuit. They also had to pay to settle the
Jones action. In this lawsuit, plaintiffs proved that defendants were legally
responsible for their financial damages, which included costs and attorney’s fees.
Under the jury’s apportionment of fault, the defendants appropriately were
required to pay for a portion, but not all, of these costs and attorney’s fees.
Defendants argue that this case is governed by Sea-Land Service, Inc. v.
Crescent Towing & Salvage Co.39 In Sea-Land, we held in a contribution action
that the plaintiffs could not recover attorney’s fees expended defending the
underlying suit.40 We have already held that this suit is not a contribution
action, but rather a lawsuit claiming that defendants breached independent
duties owed to Kadlec; therefore, Sea-Land is inapposite.
D. Negligent Monitoring and Investigation
In its lone point on cross-appeal, the plaintiffs contend that the district
court erred when it dismissed their claim against the defendants for negligent
monitoring and investigation.41 Plaintiffs argue that their complaint stated a
claim under general Louisiana negligence law, while the district court
mistakenly viewed the complaint as only asking the court to impose a duty
under the Health Care Quality Improvement Act (HCQIA) and certain Louisiana
regulations. We agree with the district court that the complaint states a claim
39
42 F.3d 960 (5th Cir. 1995).
40
Id. at 963.
41
Because this was the only claim against Drs. Parr and Baldone, dismissal of this
claim led the district court to dismiss them from the suit with prejudice. These doctors are,
however, shareholders of LAA.
22
based only on alleged duties under the HCQIA and Louisiana regulations. In
any case, to the extent that plaintiffs alleged a claim under general Louisiana
negligence law, the district court considered this argument in a motion to
reconsider and correctly concluded that this claim should be dismissed because
any duty the law imposes does not reach these plaintiffs.
E. Summary and Remand Instructions
The district court properly instructed the jury to find for the plaintiffs on
their intentional and negligent misrepresentation claims if the jury concluded
that the defendants’ letters to Kadlec were intentionally and negligently
misleading in a manner that caused injury to the plaintiffs. But the district
court’s instructions also improperly enabled the jury to find for the plaintiffs on
these claims if the defendants intentionally and negligently did not disclose their
knowledge of Dr. Berry’s drug problems, irrespective of whether the letters to
Kadlec were false or misleading. Because the verdict form only inquired as to
whether the plaintiffs’ claims for intentional and negligent misrepresentation,
in separate interrogatories, were met as to each defendant, but did not request
special findings of fact as to each of the separate possible theories, we cannot
know whether the jury’s verdict was based on the proper or improper theory.
But the fact that the jury instructions stated both a valid and invalid theory of
recovery for plaintiffs’ claims does not require a new trial because the error here
was harmless. The letters from Dr. Dennis and Dr. Preau were false on their
face and patently misleading. There is no question about the purpose or effect
of the letters. Because no reasonable juror could find otherwise, we uphold the
finding of liability against Dr. Dennis and Dr. Preau.42 But because Lakeview
42
See Carbalan v. Vaughn,
760 F.2d 662, 665 (5th Cir. 1985) (“Because a verdict for
[the plaintiff] against the [defendant] would have been impermissible as a matter of law, any
error in the jury charge on . . . liability was harmless.”).
23
Medical’s letter was not materially misleading, and because the hospital did not
have a legal duty to disclose its investigation of Dr. Berry and its knowledge of
his drug problems, the judgment against Lakeview Medical must be reversed.
The district court entered judgment consistent with how the jury allocated
fault among the entities it found to be legally responsible for the plaintiffs’
injuries. The jury’s allocation was as follows: Dr. Dennis 20%; Dr. Preau 5%;
Lakeview Medical 25%; Kadlec 17%; and Dr. Berry 33%. We have affirmed the
liability finding of the jury against the LAA defendants. But now that we have
reversed the judgment against Lakeview Medical, the question arises whether
there must be a reapportionment of fault with a corresponding change to
damages assessed against the LAA defendants. It is possible that this is
unnecessary, if under Louisiana law we can simply compare the fault
percentages of the remaining parties. But Louisiana law might also require a
reapportionment of fault and, therefore, a fresh determination of damages.
Because there was no briefing on this issue, we vacate the judgment against the
LAA defendants and remand the case to the district court to determine what, if
anything, needs to be redone on the apportionment and damages issues, and
then to enter judgment against the LAA defendants accordingly.
IV. Conclusion
The judgment of the district court is REVERSED in part, VACATED in
part, and REMANDED for proceedings consistent with this opinion.
24